Oramed Pharmaceuticals Inc. (ORMP)
Oramed Pharmaceuticals Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Oramed Pharmaceuticals Inc. (ORMP) is a Biotechnology company based in US with a market capitalization of $164.5M. Free cash flow was negative at -$11.1M. This page tracks ORMP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 13 employees · IPO May 1, 2007
Valuation
Valuation & price
$3.99as of May 23, 2026· -20.2% vs 52w high
2.6
P/E ratio
Latest-FY diluted EPS
0.82
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$164.5M
Market cap
—
Revenue growth (YoY)
0.7%
Gross margin
-$11.1M
Free cash flow (USD)
-$125.1M
Net debt
Net cash position
1.4%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 19, 2026 (EPS $-0.16)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Oramed Pharmaceuticals Inc.'s market cap?
Oramed Pharmaceuticals Inc. (ORMP) has a market capitalization of $164.5M.
What is ORMP's P/E ratio?
ORMP trades at a price-to-earnings ratio of 2.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is ORMP's price-to-book (P/B) ratio?
ORMP trades at 0.82 times book value per share.
When did Oramed Pharmaceuticals Inc. last report earnings?
ORMP last reported earnings on May 19, 2026; the next date is not yet scheduled.
Are insiders buying ORMP stock?
SEC Form 4 filings show no open-market insider buys at Oramed Pharmaceuticals Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.